Leap Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
CAMBRIDGE, Mass., March 12, 2021 /PRNewswire/ — Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the fourth quarter and year ended December 31, 2020. 2020 Leap Highlights:…
Comments Off on Leap Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results